Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-PSMA Designer T Cells in Prostate Cancer
NCT01929239Phase 2Suspended
- Sponsor
- Roger Williams Medical Center
- Start
- Mar 2006
- Primary completion
- Dec 2017
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of anti-PSMA designer T cells in prostate cancer (PCa), sponsored by Roger Williams Medical Center. Started Mar 2006; status: suspended.
02
Drugs
anti-PSMA designer T cells
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01929239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01929239.